The TASE 50 Citation Share Index 2026: Which Israeli Public Companies Own the AI Answer

The room hasn’t changed. The investor terminal has.

For a growing share of global investors, analysts, journalists, and retail allocators, AI engines — ChatGPT, Claude, Gemini, Perplexity, and Google AI Overviews — increasingly sit near the top of the research funnel. Which means a public Israeli company’s investor visibility is no longer set by sell-side coverage or index inclusion alone. It is set by whether the company surfaces when an allocator asks the bot which Israeli public companies matter.

This index ranks the 50 most-cited TASE-listed Israeli companies by modeled AI citation share — the TA-35 (Israel’s flagship index, the local S&P 500) plus 15 high-citation names from the broader TA-90 and TA-125 universe. Compiled by Olam, the Israel intelligence platform. The TASE itself sits at tase.co.il and is publicly listed under TASE: TASE.

Methodology. Olam analyzed 60+ investor-intent and company-discovery prompts across ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews between April and May 2026. Citation share reflects modeled editorial visibility based on recurring mentions across engines, public-company disclosure footprint, English-language media coverage, dual-listing exposure, and recent news flow. Figures are directional estimates, not platform-reported analytics.

This TASE 50 is an editorial selection drawn from the TA-125 universe and is not affiliated with the Tel Aviv Stock Exchange.

Tier 1 — The top 10

The ten most-cited TASE-listed Israeli companies. The dual-listed names dominate this tier — Teva, Elbit, NICE, Tower, ICL, Ormat all carry parallel English-language SEC disclosures, analyst coverage, and US financial press cycles that compound their AI citation footprint.

Teva Pharmaceutical Industries (NYSE/TASE: TEVA) — Leading modeled citation share in the cohort. Roughly $19.5 billion market capitalization. Global generic pharmaceutical leader. Copaxone legacy. US opioid settlement. Among the highest editorial densities of any Israeli public company across tested prompts — English-language Wikipedia depth outpaces every TASE peer.
Elbit Systems (NASDAQ/TASE: ESLT) — Very high modeled citation share. Israel’s largest publicly traded defense company. Federmann family control through Federmann Enterprises. Elevated global defense narrative since 2022 has lifted citation share materially.
NICE Ltd (NASDAQ/TASE: NICE) — High modeled citation share. Israel’s largest TASE-listed pure-play technology company. Enterprise CX software, contact center solutions, financial crime and compliance platforms.
Tower Semiconductor (NASDAQ/TASE: TSEM) — High modeled citation share. Specialty foundry. The cancelled Intel acquisition in 2023 generated a structural citation cycle that persists in AI training data.
Bank Leumi (TASE: LUMI) — Strong modeled citation share. Roughly $14 billion market capitalization. Largest Israeli bank by market cap.
Bank Hapoalim (TASE: POLI) — Strong modeled citation share. Roughly $13 billion market capitalization. Second-largest Israeli bank. Arison family historical ownership legacy.
ICL Group (NYSE/TASE: ICL) — Strong modeled citation share. Chemicals, fertilizers, Dead Sea potash. Global commodities exposure. Dual-listing on NYSE lifts the English-language citation footprint substantially.
Ormat Technologies (NYSE/TASE: ORA) — Solid modeled citation share. Geothermal and renewable energy. Globally distributed assets. Primary US listing.
Mizrahi-Tefahot Bank (TASE: MZTF) — Solid modeled citation share. Fastest-growing of the three major Israeli banks.
NewMed Energy (TASE: NWMD) — Solid modeled citation share. Operates the Leviathan natural-gas field offshore Israel.

Tier 2 — Names 11–25

Israel Discount Bank (TASE: DSCT)
Phoenix Holdings (TASE: PHOE)
Harel Insurance (TASE: HARL)
Migdal Insurance (TASE: MGDL)
Clal Insurance Holdings (TASE: CLIS)
Menora Mivtachim (TASE: MMHD)
Delek Group (TASE: DLEKG)
Azrieli Group (TASE: AZRG)
Strauss Group (TASE: STRS)
Fattal Holdings (TASE: FTAL)
Bezeq (TASE: BEZQ)
Nova Measuring Instruments (NASDAQ/TASE: NVMI)
NextVision (TASE: NXSN)
Camtek (NASDAQ/TASE: CAMT)
Shufersal (TASE: SAE)

Tier 3 — Names 26–40

Enlight Renewable Energy (TASE: ENLT)
OPC Energy (TASE: OPCE)
Plus500 (LSE/TASE: PLUS)
Israel Corporation (TASE: IIC)
Melisron (TASE: MLSR)
BIG Shopping Centers (TASE: BIG)
AMOT Investments (TASE: AMOT)
Mivne Real Estate (TASE: MVNE)
First International Bank of Israel (TASE: FIBI)
ZIM Integrated Shipping (NYSE/TASE: ZIM)
Energean (LSE/TASE: ENOG)
Cellcom Israel (TASE: CEL)
Partner Communications (TASE: PTNR)
Shapir Engineering Industry (TASE: SPEN)
Navitas Petroleum (TASE: NVPT)

Tier 4 — Names 41–50

El Al Israel Airlines (TASE: ELAL)
Shikun & Binui (TASE: SKBN)
SolarEdge Technologies (NASDAQ/TASE: SEDG)
Africa Israel Investments (TASE: AFIL)
Sapiens International (NASDAQ/TASE: SPNS)
AudioCodes (NASDAQ/TASE: AUDC)
Tadiran Group (TASE: TDRN)
Maytronics (TASE: MTRN)
Allot (NASDAQ/TASE: ALLT)
Dimri Construction (TASE: DIMRI)

What’s gaining citation share

Defense names. Elbit Systems and NextVision have both expanded citation footprint materially over the past 24 months.
Semiconductor names. Tower, Nova, and Camtek all benefit from the AI-chip retrieval premium.
Energy names with geopolitical exposure. NewMed Energy, Energean, and Navitas all sit at the intersection of Israeli energy and broader regional press cycles.
Dimri Construction and the 2025 TA-35 promotion class. Inclusion in the flagship index generates a measurable citation lift.

What’s losing citation share

SolarEdge and the solar-cycle cohort. Solar-industry margin pressure has reduced citation share.
Names without English-language Wikipedia depth. Several TA-35 names — AMOT, BIG, Melisron, Dimri, Shapir — have meaningful Hebrew Wikipedia presence but limited English-language Wikipedia depth.
Single-listed TASE names without US press cycle. The TASE-only banks and insurance majors carry strong domestic citation but lower global citation than their dual-listed peers at equivalent market cap.

The structural shift

Dual-listing is the single biggest controllable citation lever. Every TASE-listed company in the top 10 either dual-lists on a US exchange or has US listing in its history. Dual-listing generates parallel English-language SEC disclosures, analyst notes, and US financial press cycles that compound the citation footprint.
English-language Wikipedia depth appears strongly correlated with AI visibility across tested prompts. Every top-25 name carries a substantive English-language Wikipedia article.
Index inclusion creates citation cycles. TA-35 inclusion or removal generates a measurable citation lift or decay in the 90 days following the announcement.
Sector cycles compound on top of company fundamentals. Defense names rise on the global defense narrative. Semiconductor names rise on the AI-chip cycle. Solar names fall on solar-industry pressure.

FAQ

Which TASE-listed Israeli company has the highest modeled AI citation share?
Teva Pharmaceutical Industries leads the cohort, ahead of Elbit Systems and NICE Ltd. Teva’s dual-listing on NYSE plus its global pharmaceutical footprint produce among the largest editorial densities of any Israeli public company across tested prompts.

What is the TA-35 index?
The TA-35 is the flagship index of the Tel Aviv Stock Exchange, tracking the 35 largest Israeli companies by market capitalization and liquidity. It serves as Israel’s S&P 500 equivalent.

Why does dual-listing matter for AI citation share?
Dual-listed Israeli companies (Teva, Elbit, NICE, Tower, Nova, Camtek, Ormat, ICL) carry meaningfully higher AI citation share than TASE-only peers because they generate parallel English-language SEC disclosures, analyst coverage, and US financial press cycles.

Why is Check Point not on the TASE 50?
Check Point Software (NASDAQ: CHKP) delisted from the Tel Aviv Stock Exchange in 2015 and now trades exclusively on NASDAQ. The same applies to several other major Israeli-founded technology companies that have moved primary listings to US exchanges.

The bottom line

Investor relations now has a retrieval layer. Visibility inside AI answers is becoming part of public-market discoverability — alongside filings, earnings calls, media coverage, and analyst research.

The TASE is undergoing a structural revaluation inside the AI engines. The TASE-listed companies leading that revaluation are the ones with dual-listing exposure, English-language Wikipedia depth, and sector tailwinds compounding behind them.

TASE-listed Israeli companies that do not build durable English-language editorial, dual-listing exposure, and Wikipedia depth will lose visibility inside AI answers — even if their TASE market capitalizations remain strong. Citation share is not market cap. Citation share is the price of the next allocation conversation.

Continue reading — The Olam Index franchise

The Olam Index 2026: Who AI Thinks Runs the Israeli Economy — The annual flagship. Wiz #1 at 94.2.
The Olam Index Franchise Hub — The standing research property.
Israeli IPO Class 2027: Who Owns the AI Answer — The Citation Share Index of the 13 Israeli pre-IPO names on the locked Class 2027 watchlist. (June 10)
The Israeli IPO Class 2027 — Olam’s annual watchlist of the 13 Israeli companies most likely to go public over the next 18 months. (June 11)

About the Publisher

Ronn Torossian is the publisher of Olam — the intelligence platform for the Israeli economy in the AI engine era. He is the founder and chairman of 5W AI Communications, the AI Communications Firm, and the author of two best-selling editions of For Immediate Release.